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Abstract
The pathogenesis of persistent infection is dictated by the balance between opposing immune activation and suppression
signals. Herein, virulent Salmonella was used to explore the role and potential importance of Foxp3-expressing regulatory T
cells in dictating the natural progression of persistent bacterial infection. Two distinct phases of persistent Salmonella
infection are identified. In the first 3–4 weeks after infection, progressively increasing bacterial burden was associated with
delayed effector T cell activation. Reciprocally, at later time points after infection, reductions in bacterial burden were
associated with robust effector T cell activation. Using Foxp3
GFP reporter mice for ex vivo isolation of regulatory T cells, we
demonstrate that the dichotomy in infection tempo between early and late time points is directly paralleled by drastic
changes in Foxp3
+ Treg suppressive potency. In complementary experiments using Foxp3
DTR mice, the significance of these
shifts in Treg suppressive potency on infection outcome was verified by enumerating the relative impacts of regulatory T
cell ablation on bacterial burden and effector T cell activation at early and late time points during persistent Salmonella
infection. Moreover, Treg expression of CTLA-4 directly paralleled changes in suppressive potency, and the relative effects of
Treg ablation could be largely recapitulated by CTLA-4 in vivo blockade. Together, these results demonstrate that dynamic
regulation of Treg suppressive potency dictates the course of persistent bacterial infection.
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Introduction
Typhoid fever is a systemic, persistent infection caused by highly
adapted host-specific strains of Salmonella [1,2,3]. Human typhoid
is caused predominantly by S. enterica serotype Typhi [4], while
mice develop a typhoid-like disease following S. enterica serotype
Typhimurium infection. Interestingly, the early stages of this
infection, in both mice and humans, are usually asymptomatic or
associated with only mild, non-specific ‘‘flu-like’’ symptoms [4,5].
This represents a stark contrast to other Gram-negative bacterial
pathogens (e.g. Escherichia coli, Neisseria meningitidis, Haemophilus
influenza) that primarily cause acute infection and immediately
trigger robust systemic symptoms after tissue invasion. Thus, the
inflammatory response is blunted early after infection with
Salmonella strains that cause persistent infection, and this feature
likely facilitates long-term pathogen survival [3]. On the other
hand, the blunted inflammatory response to systemic Salmonella
infection also minimizes immune-mediated damage to host tissues
that may outweigh the immediate risk posed by the pathogen itself
[6]. Thus, dampening the immune response provides potential
advantages to pathogen and host during persistent Salmonella
infection.
Regulatory T cells (Tregs) were initially identified as a CD25-
expressing subset of CD4
+ T cells required for maintaining
peripheral immune tolerance to self-antigen. However more
recent studies clearly demonstrate their importance extends to
controlling the immune response during infection [7,8,9,10]. In
this regard, the functional importance of Tregs has been best
characterized for pathogens that cause persistent infection. For
example, depletion of CD25
+CD4
+ Tregs is associated with
enhanced effector T cell activation and reduced pathogen burden
during Leishmania major infection [11]. Similarly, reconstituting T
cell-deficient mice with CD25
+CD4
+ Tregs abrogates enhanced
pathogen clearance that occurs after reconstitution with CD25-
depleted CD4
+ T cells [11,12]. These complementary experimen-
tal approaches initially used to identify the role of CD25
+ Tregs in
host defense during L. major infection have since been reproduced
after infection with numerous other bacterial, viral, and parasitic
pathogens [8,13,14,15,16,17,18]. Interestingly, Treg-mediated
immune suppression can also play ‘‘protective’’ roles for infections
where host injury caused by the immune response outweighs the
damage caused by the pathogen itself [13,16], or when pathogen
persistence is required for maintaining protection against second-
ary infection [11,19]. Together, these findings suggest Treg-
mediated immune suppression can provide both detrimental and
protective roles in host defense against infection.
Despite these observations, identifying the functional impor-
tance of Tregs during in vivo infection has been limited, in part, by
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other CD4
+ T cell subsets. In this regard, the majority of infection
studies have experimentally manipulated Tregs based on surrogate
markers such as CD25 expression on CD4
+ T cells. However,
since CD25 expression is also a marker for activated T cells with
no suppressive function, identifying Tregs based on CD25
expression does not allow discrimination between these function-
ally distinct T cell subsets. These limitations have been recently
overcome by the identification of Foxp3 as the master regulator for
Treg differentiation, and the generation of transgenic mice that
allow precise identification or targeted manipulation of Tregs
based on Foxp3 expression [20,21,22]. These include Foxp3
GFP
reporter mice that allow ex vivo Foxp3
+ Treg isolation by sorting for
GFP-expressing cells, and Foxp3
DTR transgenic mice that co-
express a high affinity diphtheria toxin receptor (DTR) with Foxp3
[23,24]. Intriguingly, the first infection study using Foxp3
DTR mice
for Treg ablation revealed somewhat paradoxical roles for Foxp3
+
Tregs in host defense. Within the first fours days after intravaginal
herpes simplex virus 2 (HSV-2) infection, reduced inflammatory
cell infiltrate and increased viral burden were found at the site of
infection in Treg-ablated compared with Treg-sufficient mice [25].
These effects were not limited to HSV-2, nor were they restricted
to the mucosal route of infection as increased pathogen burden
associated with Foxp3
+ Treg ablation also occurred after
parenteral infection with lymphocytic choriomeningitis virus
(LCMV) and West Nile virus [25,26]. Whether these Treg-
mediated reductions in pathogen burden are limited to these
specific viral pathogens, or represent re-defined roles for Tregs
based on their manipulation using Foxp3-specific reagents are
currently undefined. Therefore, additional studies using represen-
tative mouse models of other human infections and Foxp3-specific
reagents for Treg manipulation are required. In this study, the role
of Foxp3
+ Tregs in controlling immune cell activation and the
balance between pathogen proliferation and clearance during the
natural progression of persistent bacterial infection was examined
after infection with virulent Salmonella.
Results
Persistent Salmonella infection in F1 129SvJ X C57BL/6
mice
Commonly used inbred mouse strains have discordant levels of
innate resistance to virulent S. enterica serotype Typhimurium
based primarily on whether a functional allele of Nramp1 is
expressed [27,28]. For example, C57BL/6 mice express a
functionally defective, naturally occurring variant of Nramp1
and thus, are inherently susceptible to infection with virulent
Salmonella dying within the first few days from uncontrolled
bacterial replication. By contrast, 129SvJ mice, which express
wild-type Nramp1 (Nramp1-sufficient), are inherently more
resistant developing a persistent infection instead [29,30]. Since
transgenic mouse tools for Treg manipulation based on Foxp3-
expression are available primarily on the susceptible, Nramp1-
defective C57BL/6 background, we sought to exploit the
autosomal dominant resistance to Salmonella conferred by wild-
type Nramp1, and the X-linked inheritance of Foxp3 transgenic
mice by examining infection in resistant F1 129SvJ X C57BL/6
mice [30]. Similar to results after infection with virulent Salmonella
in 129SvJ mice, progressively increasing bacterial burdens are
found throughout the first 3–4 weeks after infection in F1 129SvJ
X C57BL/6 mice (Figure 1A). By contrast, Nramp1-defective
C57BL/6 mice died within the first week after infection from
overwhelming bacterial replication despite a 100-fold reduction in
Salmonella inocula (Figure 1A). The progressively increasing
bacterial burden within the first 3–4 weeks after Salmonella
infection in F1 129SvJ X C57BL/6 mice parallels dramatic
changes in both spleen size and absolute number of splenocytes
(Figure 1B and C). Each of these parameters increased within the
first three weeks after infection and declined subsequently at later
time points that directly coincide with changes in Salmonella
bacterial burden (Figure 1A–C). These findings demonstrate an
interesting dichotomy in infection tempo between early (first 3–4
weeks) and later time points during persistent Salmonella infection
in resistant F1 129SvJ X C57BL/6 mice.
Delayed T cell activation early after Salmonella infection
Given the importance of T cells in host defense against
Salmonella [31,32,33], the expansion and activation kinetics for
CD4
+ and CD8
+ T cells during this persistent infection were each
enumerated. Although the absolute numbers of both cell types
increased in parallel with the absolute numbers of splenocytes, a
progressive and steady increase in percent CD4
+ T cells became
readily apparent beginning week three post-infection (Figure 1D).
By contrast, the percent CD8
+ T cells remained essentially
unchanged throughout these same time points. Additional





+ T cells both increased sharply
beginning week 3, and were sustained at high levels through week
7 after infection (Figure 2A). Furthermore, the kinetics of T cell
activation based on CD44 and CD62L expression directly
paralleled the kinetics whereby CD4
+ and CD8
+ T cells each
became primed for IFN-c production (Figure 2B). Thus, the
kinetics of CD44 and CD62L expression and IFN-c production
each reveal delayed T cell activation early after infection, not
peaking until weeks 3 to 4, that is followed by more sustained T
cell activation thereafter.
Given the durability whereby T cells maintain changes in CD44
and CD62L expression, and IFN-c production after activation, the
expression of more transient T cell activation markers such as
CD25 and CD69 were also quantified throughout persistent
Salmonella infection. CD25 and CD69 expression on CD4
+ and
Author Summary
The balance between immune activation and suppression
is intricately controlled allowing optimal host defense
against infection, while simultaneously minimizing collat-
eral immune-mediated damage to host tissues. Although
regulatory T cells have been implicated to play critical roles
in sustaining this balance, their role in controlling the
dynamic changes in immune cell activation during the
natural progression of persistent infection are undefined.
Herein, we explored the relative importance of regulatory
T cells in controlling infection tempo using a model of
persistent Salmonella infection representative of human
typhoid. Early after infection when the bacterial burden is
progressively increasing, the activation of protective
immune components is delayed, and this coincides with
increased regulatory T cell suppressive potency. Converse-
ly, later during infection when reductions in bacterial
burden occur, protective immune components are highly
activated and regulatory T cell suppressive potency is
markedly diminished. Moreover, the tempo of persistent
Salmonella infection is controlled by regulatory T cells
because ablation of these cells early after infection when
their suppressive potency is increased accelerates bacterial
eradication, while their ablation later when their suppres-
sive potency is reduced causes no significant effects. Thus,
regulatory T cell suppression controls the tempo of
persistent Salmonella infection.
Foxp3
+ Treg Potency Dictates Persistent Infection
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+ T cells each peaked between weeks 3 and 4 post-infection
(Figure 2C). However consistent with the transient nature of their
expression, CD25 and CD69 expression each declined to baseline
levels over the next 2 to 3 weeks. Thus, the sharp increase in T cell
activation that occurs between weeks 3 and 4 after Salmonella
infection is confirmed using both transient (CD25, CD69) and
more stable (CD44, CD62L, IFN-c) markers of T cell activation.
Interestingly, the overall kinetics for T cell activation beginning
week 3 after infection directly parallels when reductions in
bacterial burden begins to occur, and suggests dampened T cell
activation early after infection allows progressively increasing
bacterial burden, while enhanced T cell activation later facilitates
bacterial clearance.
CD4
+ T cell-mediated Salmonella clearance during
persistent infection
To determine the overall importance and individual contribu-
tion provided by each T cell subset in bacterial clearance during
the natural course of persistent Salmonella infection, the impacts of
CD4
+ and/or CD8
+ T cell depletion were determined. Anti-
mouse CD4 and anti-mouse CD8 depleting antibodies were
administered beginning day 31 post-infection. In initial studies, we
found that 750 mg of each could deplete the respective T cell
subset with $99% efficiency even in Salmonella-infected mice that
contain expanded T cell numbers (Figure 3A). With sustained
CD4
+ T cell depletion, significantly increased numbers of
recoverable Salmonella CFUs were found day 6 (day 31+6) after
the administration of anti-mouse CD4 compared with isotype
control antibody (Figure 3B). Moreover, the magnitude of this
difference became even more pronounced by day 14 (day 31+14)
after antibody treatment. By contrast, CD8
+ T cell depletion alone
or together with CD4
+ T cell depletion did not cause significant
changes in Salmonella bacterial burden except in the spleen day 14
after antibody treatment where combined depletion of both CD4
+
and CD8
+ T cells resulted in increased numbers of recoverable
Salmonella CFUs compared to CD4
+ T cell depletion alone
(Figure 3B). Together, these results demonstrate an essential role
for CD4
+ T cells in the clearance of persistent Salmonella infection,
and these findings are consistent with the previously reported
requirement for this T cell subset in controlling the replication of
attenuated Salmonella in susceptible Nramp1-defective mice [31].
Moreover, an essential role for CD4
+ T cells in host defense during
persistent infection in resistant mice is further supported by the
sharp increase in overall percentage and activation of these cells
which coincides with reductions in Salmonella bacterial burden
beginning week 3 post-infection (Figure 1 and 2).
Parallel expansion of Foxp3
+ Tregs and non-Treg CD4
+
cells during persistent infection
The requirement for CD4
+ T cells in bacterial clearance during
persistent Salmonella infection may reflect contributions from either
Foxp3-negative effector or Foxp3
+ regulatory T cells (Tregs). To
characterize the relative contributions of each CD4
+ T cell subset
during persistent infection, our initial studies enumerated the
percent Foxp3
+ cells among CD4
+ T cells and the expansion
kinetics of Foxp3
+ and Foxp3-negative CD4
+ T cells during
persistent infection. Interestingly despite dramatic shifts in the
percent and absolute number of CD4
+ T cells among splenocytes,
the percent Foxp3
+ Tregs among CD4
+ T cells remains remarkably
stable and essentially unchanged at approximately 10% throughout
the infection (Figure 4A and B). By extension, the absolute numbers
of Foxp3
+ Tregs and Foxp3-negative effector CD4
+ T cells were
also found to expand in parallel (Figure 4C). These findings suggest
Figure 1. Tempo of persistent Salmonella infection in F1 129SvJ
X C57BL/6 mice. A. Recoverable CFUs at the indicated time points
after infection from the spleen (top) and liver (bottom) after infection
with 10
4 S. enterica serotype Typhimurium (strain SL1344) in F1 129SvJ
X C57BL/6 (left) or 10
2 in C57BL/6 (right) mice. {, all mice died or were
moribund. B. Spleen size in F1 129SvJ X C57BL/6 mice at the indicated
time points after infection. Absolute number of splenocyte cells (C) and
percent CD4
+ and CD8
+ cells (D) in F1 129SvJ X C57BL/6 mice at the
indicated time points after infection. These data reflect eight to ten
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+ Tregs among non-Treg effector
CD4
+ T cells alone does not account for the shift in relative T cell
activation and change in infection tempo at early compared to late
time points during persistent Salmonella infection.
Dynamic shifts in Foxp3
+ Treg suppressive potency
Since defined inflammatory cytokines and pathogen associated
molecular patterns have each been shown to control Treg
suppressive potency after stimulation in vitro [34,35,36,37,38,39],
we explored the possibility that intact pathogens and the ensuing
immune response would also dictate shifts in Treg suppressive
potency after infection in vivo. By extension, these shifts in relative
Treg suppressive potency may impact the activation of non-Treg
effector cells and overall tempo of persistent infection. According-
ly, we compared the suppressive potency for Foxp3
+ Tregs isolated
at early (day 5) and late (day 37) time points during persistent
Salmonella infection. These specific time points where chosen
because they reflect highly pronounced contrasts in T cell
activation and directional changes in Salmonella bacterial burden,
yet have comparable bacterial burdens (Figure 1 and 2). Nramp1-
sufficient F1 Foxp3
GFP reporter hemizygous male mice derived by
intercrossing 129SvJ males with Foxp3
GFP/GFP females (on the
C57BL/6 background) that simultaneously allow persistent
Salmonella infection and for all Tregs to be isolated based on cell
sorting for GFP
+(Foxp3
+) cells were used in these experiments [23]
(Figure 5A). By first enriching for CD4
+ cells using negative
selection, GFP
+(Foxp3
+) Tregs could be routinely isolated from
naı ¨ve and Salmonella-infected F1 Foxp3
GFP reporter mice each with
$99% purity (Figure 5B). Potential differences in suppressive
potency for GFP
+(Foxp3
+) Tregs isolated at each time point after
infection were quantified by measuring their ability to inhibit the
proliferation of responder CD4
+ T cells isolated from naı ¨ve
CD45.1 congenic mice after non-specific stimulation in vitro using
previously defined methods [40,41,42].
Figure 2. T cell activation kinetics during persistent Salmonella infection. A. Percent CD44
hiCD62L
lo cells among CD4
+ and CD8
+ T cells at the
indicated time points after infection with 10
4 S. enterica serotype Typhimurium in F1 129SvJ X C57BL/6 mice. B. Percent IFN-c producing CD4
+ and
CD8
+ T cells after Salmonella infection and ex vivo stimulation with anti-CD3/CD28 antibody (black histogram) or no stimulation control (shaded
histogram) at the indicated time points after infection. C. Expression levels of CD25 (top) and CD69 (bottom) by CD4
+ and CD8
+ T cells at the
indicated time points post-infection (black histograms) compared to naı ¨ve F1 control mice (shaded histograms). These data reflect eight to ten mice
per time point representative of three independent experiments.
doi:10.1371/journal.ppat.1001043.g002
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GFP reporter mice
prior to infection, the suppressive potency of Tregs isolated from
mice day 5 after Salmonella infection was enhanced (Figure 5C). At
the same Treg to responder T cell ratio, Foxp3
+ Tregs from mice
day 5 after infection consistently inhibited responder CD45.1
+ T
cell proliferation (CFSE dilution) more efficiently. These differ-
ences in suppression were eliminated when a 2-fold reduction in
Treg to responder cell ratio from mice day 5 post-infection
compared with undiluted Tregs from naı ¨ve mice were co-cultured
with a fixed number of naı ¨ve responder cells (Figure 5C). In sharp
contrast to increased suppression that occurs at this early post-
infection time point, the suppressive potency for Tregs isolated
from mice day 37 after infection was significantly reduced.
Compared with Tregs isolated from mice 5 days after infection,
the efficiency whereby Tregs isolated day 37 post-infection
inhibited the proliferation of responder CD45.1
+ T cells was
reduced approximately 4-fold; and compared with Tregs isolated
from naı ¨ve mice, their suppressive potency was reduced
approximately 2-fold (Figure 5C). In other words, a 50% reduction
in Treg to responder cell ratio for Tregs isolated from naı ¨ve mice,
and a 75% reduction in ratio for Tregs from mice day 5 after
infection each suppressed responder cell proliferation to the same
Figure 3. CD4
+ T cells are required for reductions in Salmonella pathogen burden during persistent infection. A. Percent CD4
+ and CD8
+
T cells 14 days after treatment with each indicated antibody in mice beginning day 31 after Salmonella infection. B. Recoverable Salmonella CFUs in
the spleen (left) and liver (right) for mice treated with each antibody for six days (31+6) or 14 days (31+14). These data reflect six to twelve mice per
time point representative of three independent experiments each with similar results. Bar, standard error. *, p,0.05; **, p,0.001.
doi:10.1371/journal.ppat.1001043.g003
Figure 4. Parallel expansion of Foxp3
+ and Foxp3-negative CD4
+ T cells during persistent Salmonella infection. Representative FACS
plots (A) and composite data (B) indicating percent Foxp3
+ cells among CD4
+ T cells at the indicated time points after infection with 10
4 Salmonella in
F1 129SvJ X C57BL/6 mice. C. Total numbers of Foxp3
+CD4
+ Tregs and Foxp3-negative non-Treg CD4
+ T cells among splenocytes during persistent
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+(Foxp3
+) Tregs isolated from mice day 37
after infection. These results demonstrate that although the ratio of
Foxp3
+ Tregs and non-Treg effector CD4
+ T cells remains
unchanged, shifts in Treg suppressive potency that directly parallel
the kinetics of T cell activation and infection tempo occur during
the progression of persistent Salmonella infection.
In complementary experiments, the relative suppressive envi-
ronment dictated by Foxp3
+ Tregs during Salmonella infection was
further characterized. Specifically the expansion of adoptively
transferred antigen-specific T cells after stimulation with cognate
peptide at defined time points during persistent infection was
enumerated. This approach exploits the use of F1 129SvJ X
C57BL/6 mice as recipients for adoptively transferred T cells from
TCR transgenic mice on the C57BL/6 background [43]. As a
control to identify the overall contribution of Tregs in suppressing
the expansion of adoptively transferred T cells in vivo,F 1Foxp3
DTR
hemizygous male mice derived from intercrossing 129SvJ males
with Foxp3
DTR/DTR female mice (on the C57BL/6 background),
which allows targeted ablation of Foxp3
+ Tregs by administering
low-dose diphtheria toxin (DT) were used initially [24]. We found
1.0 mg (50 mg/kg) DT given on two consecutive days was sufficient
for $99% ablation of Foxp3
+ Tregs, and continued DT dosing
(0.2 mg every other day) was able to maintain this level of Treg
ablation in Foxp3
DTR mice on the F1 background (Figure 6A).
These results are consistent with the reported efficiency whereby
Foxp3
+ Tregs are selectively ablated in Foxp3
DTR mice on the
C57BL/6 background [24]. Although in vivo injection of cognate
OVA257–264 peptide could stimulate only modest levels of
expansion for adoptively transferred T cells from OT-1 TCR
transgenic mice in Treg-sufficient mice, the expansion magnitude
was increased .50-fold in Treg-ablated F1 Foxp3
DTR mice
(Figure 6B). Importantly, the expansion of these adoptively
transferred T cells was antigen-dependent because very few cells
could be recovered from either Treg-ablated or Treg-sufficient
recipient mice without peptide stimulation. Thus, Tregs actively
suppress the expansion of peptide stimulated antigen-specific T
cells in vivo, and the relative expansion of these exogenous cells is a
reflection of Treg suppressive potency.
Using this approach, the relative expansion of exogenous T cells
from OT-1 TCR transgenic mice after adoptive transfer into
Salmonella infected F1 129SvJ X C57BL/6 and stimulation with
cognate OVA257–264 peptide was enumerated. The percent and
total numbers of OT-1 T cells was increased 4-fold and 5-fold,
respectively, after adoptive transfer into mice at late (day 37)
compared with early (day 5) time points during persistent infection
(Figure 6C). Thus, the in vivo environment at later compared with
early time points during persistent Salmonella infection is signifi-
cantly more permissive for peptide-stimulated T cell expansion.
These results, together with the reductions in suppressive potency
for GFP
+(Foxp3
+) cells isolated ex vivo from mice at early compared
with late time points (Figure 5C), and the critical role for Foxp3
+
Tregs in controlling exogenous T cell expansion in response to
cognate peptide (Figure 6A and B) clearly illustrate reductions in
Treg suppressive potency occur from early to late points during
persistent Salmonella infection. Furthermore, given the sharp
dichotomy in infection tempo at these specific time points, these
results suggest enhanced Treg suppression early after infection
restrains effector T cell activation that allows progressively
increasing Salmonella bacterial burden, while diminished Treg
suppression at later time points allows enhanced T cell activation
that more efficiently controls the infection.
Dynamic regulation of Treg-associated molecules that
control suppression
Multiple Treg-associated cell surface and secreted molecules
have been implicated to mediate immune suppression by these
cells. For example, increased expression of CTLA-4, IL-10, Tgf-b,
Granzyme B, ICOS, PD-1, and CD39 each have been shown
independently to coincide with enhanced Treg suppressive
potency [44,45,46,47,48,49,50,51,52,53], while expression of
other Treg cell-intrinsic molecules (e.g. GITR, OX40) each
parallel reductions in suppressive potency [54,55,56]. Although
the relative importance of each defined molecule varies signifi-
cantly depending upon the experimental model used, the relative
Figure 5. Dynamic regulation of Treg suppressive potency
during persistent Salmonella infection. A. Percent Foxp3
+ (left) and
GFP
+ (right) cells among CD4
+ T cells from F1 and F1 Foxp3
GFP/2 mice.
B. Expression of Foxp3
+ after cell sorting for GFP
+CD4
+ cells from F1
Foxp3
GFP/2 mice at the indicated time points after infection. C. Percent
CFSE
lo cells among CD45.1
+CD4
+ responder T cells (Tresp) after co-
culture with the indicated ratio of GFP
+(Foxp3
+) Tregs isolated from
mice at each time point after infection and stimulation with anti-CD3/
CD28 (line histogram) or no stimulation (shaded histogram) (top).
Relative suppression of CFSE dilution in CD45.1
+CD4
+ responder T cells
by GFP
+(Foxp3
+) Tregs isolated at each time point after infection
normalized to the suppression conferred by Tregs from naı ¨ve mice co-
cultured with responder T cells at a 1:1 ratio (dotted line) (bottom).
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inhibit suppression likely dictates the overall suppressive potency of
Tregs. Therefore, we quantified the relative expression of each
molecule on Foxp3
+ Tregs to explore how the observed shifts
in suppression potency from early to late time points during
persistent Salmonella infection correlate with changes in their
expression (Figure 7A and Figure S1). Consistent with the drastic
reduction in suppressive potency, significant shifts in expression for
Figure 6. Shifts in Treg-mediated in vivo suppression during
persistent Salmonella infection. A. Representative FACS plots
demonstrating the efficiency whereby Foxp3
+ Tregs are ablated with
DT treatment in F1 Foxp3
DTR compared with F1 Foxp3
WT (F1) control
mice. The numbers indicate the percent Foxp3-expressing among CD4
+
T cells after DT treatment. B. Representative FACS plots demonstrating
percent (top) CD90.1
+ OT-1 T cells among CD8
+ splenocytes and total
number (bottom) of CD90.1
+CD8
+ splenocytes in Treg-sufficient (F1) or
Treg-ablated (F1 Foxp3
DTR) mice day 5 after injection of OVA257–264
peptide or no peptide controls. C. Representative FACS plots (top)
demonstrating percent CD90.1
+ OT-I T cells among CD8
+ splenocytes
and composite data (bottom) depicting percent and total number
CD90.1
+CD8
+ splenocytes after adoptive transfer into mice at the
indicated time points after Salmonella infection and peptide stimula-
tion. These data represent six to ten mice per group combined from
three independent experiments each with similar results. Bar, standard
error. **, p,0.01.
doi:10.1371/journal.ppat.1001043.g006
Figure 7. Expression of Treg-associated effector molecules
during persistent Salmonella infection. A. The relative expression of
CTLA-4 and GITR on Foxp3
+ Tregs (line histogram) or Foxp3-negative
CD4
+ T cells (shaded histogram) at the indicated time points during
persistent infection. B. Expansion of Salmonella FliC431–439-specific CD4
+
T cells, and Foxp3-expression among these cells after staining with
FliC:I-A
b tetramer and magnetic bead enrichment. The numbers in each
plot represent the average cell number and percent Foxp3
+ cells from
12 mice per time point combined from four independent experiments.
C. Expression of CTLA-4 or GITR on FliC431–439-specific Foxp3
+ Tregs (line
histogram) and Foxp3-negative CD4
+ T cells (shaded histogram) at early
(day 5) and late (day 37) time points during persistent Salmonella
infection. These data reflect six mice per time point representative of
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infection were identified. For example, molecules that have
independently been associated with diminished Treg suppression
potency such as reduced CTLA-4 and increased GITR expression
were found for Foxp3
+ Tregs from mice day 5 compared with day
37 after infection [46,54,55] (Figure 7A). By contrast, more modest
or minimal changes were found for other Treg-associated
molecules implicated to mediate suppression (e.g. CD39, IL-10,
Granzyme B, PD-1, and Tgf-b) [47,48,49,50,51,52,53,56] (Figure
S1). Thus, reduction in Treg suppressive potency during the
progression of persistent Salmonella infection directly parallels
reduced CTLA-4 and increased GITR expression that each
independently correlates with this shift in suppression.
Salmonella FliC-specific CD4
+ T cells expand during
persistent infection
Given the importance of pathogen-specific Tregs in controlling
pathogen-specific effector cells in other models of persistent
infection [57,58,59], the expansion kinetics and relative expression
of Treg-associated effector molecules were also characterized for
Salmonella-specific Tregs. The best characterized Salmonella-specific,
I-A
b-restricted MHC class II antigen is the flagellin FliC431–439
peptide [60]. Using tetramers with specificity for this antigen and
magnetic bead enrichment, naı ¨ve C57BL/6 mice have been
estimated to contain ,20 FliC431–439-specific CD4
+ T cells [61].
Using these sametechniques,wefind similar numbersofFliC431–439-
specific CD4
+ T cells in naı ¨ve F1 mice prior to Salmonella infection
(Figure 7B). As predicted after Salmonella infection, the numbers of
these FliC431–439-specific CD4
+ T cells expand reaching ,10-fold
and 20-fold increased cell numbers day 5 and 37 post-infection,
respectively (Figure 7B). Interestingly, for FliC431–439-specific CD4
+
cells identified in this manner, ,10% were Foxp3
+ in F1 mice
prior to and at each time point after infection (Figure 7B). Thus,
FliC431–439-specific Tregs and effector T cells expand in parallel
during this persistent infection, and these results are consistent with
the stable percentage of Foxp3
+ Tregs among bulk CD4
+ Tc e l l s
(Figure 4). Although the relatively small number (,1–2 cells per
mouse) of FliC431–439-specific Foxp3
+ Tregs in naı ¨ve mice precluded
furtheranalysisbeyondtheseabsolute cellnumbers,theexpansionof
FliC431–439-specific Tregs and non-Treg effector CD4
+ Tc e l l sa t
early and late time points after infection allowed the relative
expression of likely determinants of Treg suppression to be
characterized. FliC431–439-specific Tregs were found to down-
regulate CTLA-4 and up-regulate GITR expression, as infection
progressed from early to late time points to a similar extent in
FliC431–439-specific compared with bulk Tregs at these same time
pointsafterinfection(Figure7Aand C).Thus,therelativeexpression
of Treg-intrinsic molecules known to stimulate or impede immune
suppression occurs for both pathogen-specific and bulk Foxp3
+ Treg
cells, and these changes directly coincide with reductions in their
suppressive potency that occurs from early to late time points during
persistent infection.
Reduced impact of Treg-ablation from early to late time
points during persistent infection
To more definitively identify the relative importance of Treg-
mediated immune suppression on the progression of persistent
Salmonella infection, the impacts of Treg ablation on infection
tempo and T cell activation were enumerated at early and late
time points after infection. Given the striking contrasts in
suppressive potency for Foxp3
+ Tregs, directional changes in
bacterial burden, and effector T cell activation between mice day 5
versus day 37 post-infection, the relative impact caused by Treg
ablation using F1 Foxp3
DTR mice (Figure 6A) on infection tempo
beginning at these time points were enumerated. In agreement
with their essential role in maintaining and sustaining peripheral
tolerance [24], Treg-ablated mice began to appear lethargic and
dehydrated beginning day 8 after the initiation of DT treatment in
Salmonella-infected mice. Thus, the impacts of Treg ablation on
infection tempo and T cell activation were limited to discrete 7-
day windows during persistent Salmonella infection. For mice that
received DT beginning day 5 post-infection, significantly reduced
numbers of recoverable Salmonella CFUs were found for Treg-
ablated F1 Foxp3
DTR compared with Treg-sufficient F1 Foxp3
WT
control mice 6 days after the initiation of DT treatment (day 5+6)
(Figure 8A). These reductions in bacterial burden with Treg
ablation early after infection were paralleled by significantly
increased T cell activation (percent CD44
hiCD62
lo T cells)
(Figure 8B). Importantly, the reductions in Salmonella bacterial
burden in Treg-ablated mice cannot be attributed to non-specific
effects related to DT treatment because both Treg-ablated F1
Foxp3
DTR and Treg-sufficient F1 Foxp3
WT control mice each
received identical doses of this reagent, nor could they be
attributed to cell death-induced inflammation triggered by dying
Tregs because no significant reductions in recoverable CFUs were
found for F1 Foxp3
DTR/WT heterozygous female mice where
,50% Tregs express the high affinity DT receptor and are
eliminated following DT treatment (Figure S2). By contrast, Treg
ablation beginning later after infection (day 37) when T cells are
already highly activated caused no significant change in Salmonella
bacterial burden and only a modest incremental increase in T cell
activation between Treg-ablated F1 Foxp3
DTR compared with
Treg-sufficient F1 Foxp3
WT control mice (Figure 8A and B). Thus,
the relative impact of Treg ablation at early and late time points
on infection outcome directly parallel the differences in their
suppressive potency. Together, these results demonstrate en-
hanced Treg suppressive potency at early infection time points
restrains effector T cell activation and allows progressively
increasing bacterial burden. By extension, Treg ablation at these
early time points markedly increases T cell activation and
significantly reduces the bacterial burden (Figure 8A and B).
Reciprocally, at later time points after infection when Treg
suppressive potency is diminished, the relative contribution of
Foxp3
+ Tregs on T cell activation and bacterial clearance is
reduced (Figure 8A and B). Thus, dynamic regulation of Treg
suppression dictates the balance between pathogen proliferation
and clearance during the course of persistent Salmonella infection.
Given the drastic shifts in Treg-associated expression of CTLA-
4 and GITR that each correlates with the reduced suppressive
potency of these cells from early to late time points during
persistent Salmonella infection, additional experiments sought to
identify the relative importance of these molecules in dictating
infection tempo using well characterized CTLA-4 blocking (clone
UC10-4F10) or GITR-stimulating (clone DTA-1) monoclonal
antibodies [54,62,63,64]. Consistent with the essential role for
CTLA-4 in Treg suppression during non-infection conditions in
vivo [46], significant reductions in Salmonella recoverable CFUs and
accelerated T cell activation were found with CTLA-4 blockade
initiated beginning day 5 after Salmonella infection, and the
magnitude of these changes paralleled those following DT-induced
Treg ablation in F1 Foxp3
DTR mice (Figure 8C and D). Since
Foxp3-negative cells also express CTLA-4, albeit at significantly
reduced levels compared with Foxp3
+ Tregs (Figure 7), we further
explored the relative contribution of CTLA-4 blockade in the
absence of Foxp3
+ Tregs. Consistent with the reduced levels of
CTLA-4 expression on Foxp3-negative CD4
+ T cells, the effects of
CTLA-4 blockade were eliminated with Foxp3
+ Treg ablation
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37) when CTLA-4 expression is down-regulated on Foxp3
+ Tregs,
no significant change in Salmonella bacterial burden or T cell
activation occurred with CTLA-4 blockade (Figure 8C and D). By
contrast to these results with CTLA-4 blockade that directly
recapitulates the effects of Treg ablation at early and late time
points during persistent infection, treatment with a monoclonal
antibody that stimulates cells through GITR caused no significant
changes in Salmonella bacterial burden or T cell activation when
initiated at either early or late time points during persistent
infection (Figure 8E and F). Together, these results suggest the
dynamic regulation of Treg suppressive potency during Salmonella
Figure 8. Relative impacts after Treg ablation on the tempo of persistent Salmonella infection. A. Number of recoverable Salmonella CFUs
from spleen (top) and liver (bottom) in Treg-ablated F1 Foxp3
DTR compared with Treg-sufficient F1 control mice when DT treatment was initiated at
either early (day 5) or late (day 37) time points during persistent infection. B. Percent CD44
hiCD62L
lo among CD4
+ T cells in Treg-ablated F1 Foxp3
DTR
compared with Treg-sufficient F1 control mice when DT treatment was initiated on either day 5 or day 37 during persistent infection. C. Number of
recoverable Salmonella CFUs from spleen (top) and liver (bottom) following CTLA-4 blockade beginning at either early (day 5) or late (day 37) time
points post-infection in F1 mice. D. Percent CD44
hiCD62L
lo among CD4
+ T cells when CTLA-4 blockade was initiated at either early (day 5) or late (day
37) time points post-infection. E. Number of recoverable Salmonella CFUs from spleen (top) and liver (bottom) following treatment with GITR-




cells when GITR stimulation was initiated at either early (day 5) or late (day 37) time points post-infection. These data reflect six to ten mice per group
combined from two to three independent experiments each with similar results. Bar, standard error. *, p,0.05.
doi:10.1371/journal.ppat.1001043.g008
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sion, and reduced CTLA-4 expression by Tregs during the
progression of this persistent infection dictates reduced suppression
with enhanced effector T cell activation and bacterial clearance.
Discussion
The balance between immune activation required for host
defense, and immune suppression that limits immune-mediated
host injury is stringently regulated during persistent infection [6,7].
Although Tregs have been widely implicated to control the
activation of immune host defense components during infection,
their role in dictating the natural progression of persistent infection
remains undefined. In this study, we report two distinct phases of
effector T cell activation with opposing directional changes in
pathogen burden in a mouse model of persistent Salmonella
infection. Delayed T cell activation associated with increasing
bacterial burden occurs early, while enhanced T cell activation
that parallels reductions in pathogen burden occurs later during
infection. Remarkably, significant reductions in Treg suppressive
potency between early and late infection time points directly
coincide with these differences in infection tempo. In complemen-
tary experiments, the significance of these shifts in Treg
suppressive potency were verified by directly enumerating the
relative impact of Treg ablation on infection tempo at early and
late infection time points. Together, these results demonstrate
dynamic changes in Foxp3
+ Treg suppressive potency dictate the
natural course and progression of this persistent infection.
Along with two recent studies characterizing infection outcome
with Foxp3
+ Treg ablation after mucosal HSV-2, systemic LCMV,
and footpad West Nile virus infections [25,26], these are the first
studies to characterize the importance of Tregs during infection
using Foxp3
DTR transgenic mice. These results comparing infection
outcome after Treg manipulation based on their lineage-defining
marker, Foxp3, allow the importance of Tregs to be more precisely
characterized compared with other methods that identify and
manipulate Tregs using surrogate markers (e.g. CD25 expression)
that are not expressed exclusively by these cells. Interestingly,
while Treg ablation caused increased pathogen burden, delayed
arrival of acute inflammatory cells, and accelerated mortality after
HSV-2, LCMV, or West Nile virus infections [25,26], we find
contrasting reductions in pathogen burden and increased T cell
activation with Treg ablation at early, but not late time points
during persistent Salmonella infection. However, the reductions in
Salmonella pathogen burden with early Treg ablation are consistent
with reduced Mycobacterium tuberculosis pathogen burden after
partial Treg depletion using bone marrow chimera mice
reconstituted with mixed cells containing congenically-marked
Foxp3
+ Tregs and Foxp3-deficient cells [65]. Together, these
studies comparing infection outcome after Treg ablation using
Foxp3-specific reagents highlight interesting and divergent func-
tional roles for Foxp3
+ Tregs during specific infections. The
reasons that account for these differences – whether they are
related to differences between bacterial versus viral pathogens or
between pathogens that primarily cause acute versus persistent
infection, are important areas for additional investigation, and
require the characterization of infection outcomes after Treg
manipulation using Foxp3-specific reagents with other pathogens.
The dynamic regulation of Treg suppressive potency during
Salmonella infection we demonstrate here is consistent with the
ability of inflammatory cytokines and purified Toll-like receptor
(TLR) ligands to each control Treg suppression after stimulation in
vitro [34,35,36,37,38,39]. However, since these stimulation signals
in isolation trigger opposing directional changes in suppressive
potency, the specific contribution for each on changes in Treg
suppression during infection is unclear. Therefore, the cumulative
impact of multiple TLR ligands expressed by intact pathogens and
the ensuing immune response on changes in Treg suppression is
best characterized for Tregs isolated directly ex vivo after infection.
The increased suppressive potency for Foxp3
+ Treg at early time
points after Salmonella infection we demonstrate here is consistent
with the increased suppressive potency for CD25
+CD4
+ cells
isolated day 5 after Plasmodium yoelii and day 10 after HSV-1
infection, as well as CD25
+CD4
+ cells isolated in the acute (day 12)
and chronic phase (day 28) after Heligmosomoides polygyrus infection
[14,66,67]. However, our results build upon and extend the
significance of these findings in three important respects. First, by
isolating Tregs based on Foxp3 rather than CD25 expression, the
limitations imposed by contaminating non-Treg CD25
+ effector T
cells in subsequent ex vivo functional analysis is bypassed.
Secondly, although an increase in CD25
+CD4
+ T cell
suppression early after infection when pathogen proliferation
occurs, potential shifts in Treg suppression at later time points
during the natural progression of persistent infections has not been
previously demonstrated. In this regard, the relatively short time
interval that separates pathogen proliferation and clearance during
persistent Salmonella infection is ideally suited for comparing
differences in relative importance and suppressive potency for
Tregs during these contrasting stages of infection. Using this
model, we demonstrate significant reductions in Treg suppressive
potency between early and late time points after infection that
enables robust immune cell activation required for pathogen
clearance. Despite these changes in suppressive potency, the
percentage of Tregs among bulk and Salmonella FliC-specific CD4
+
T cells each remained relatively constant throughout infection.
These findings are consistent with the stable ratio of Tregs to
effector CD4
+ T cells during other models of persistent infection,
and represent a striking contrast to the selective priming and
expansion of pathogen-specific Foxp3-negative CD4
+ T cells that
occurs after acute Listeria monocytogenes infection [58,65,68,69].
Thus, the priming and expansion of pathogen-specific Tregs may
be an important distinguishing feature between pathogens that
cause acute rather than persistent infection.
The development and refinement of methods for MHC class II
tetramer staining and magnetic bead enrichment has allowed the
precise identification of very small numbers of T cells with defined
specificity from naı ¨ve mice [61]. Using these techniques, we find in
this and a recent study [69] that Foxp3
+ Tregs comprise
approximately 10% of CD4
+ T cells with specificity to both the
FliC431–439 and 2W1S52–68 peptide antigens, respectively. Togeth-
er, these results suggest previously under-appreciated overlap in the
repertoire of antigens recognized by Foxp3
+ Tregs compared with
non-Treg CD4
+ effectors in naı ¨ve mice [70,71,72]. However, more
considerable overlap in the specificity of these two cell types is
consistent withtheTCR repertoiresofhumanperipheralTregsand
non-Tregs based on genomic analysis of TCR sequences [73,74].
Thus, additional studies that examine the percent Tregs among
CD4
+ T cells with other defined antigen-specificities using recently
developed tetramer-based enrichment techniques are warranted.
Lastly, by enumerating the relative expression of defined Treg-
associated molecules that have been implicated to directly mediate
or inhibit suppression, the complexity whereby Tregs maintain the
balance between immune activation and suppression becomes
more clearly defined. For example, shifts in suppressive potency
for Tregs isolated from early compared to late time points during
persistent infection are paralleled by significant changes in the
expression of numerous Treg cell-intrinsic molecules that have
been demonstrated in other experimental models to control and/
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particular, the drastic reductions in suppressive potency that
occurs for Tregs isolated from mice day 5 compared with day 37
after infection is associated with significant reductions in CTLA-4
expression and increased expression of GITR on both bulk Foxp3
+
Tregs and Salmonella FliC431–439-specific Foxp3
+ Tregs (Figure 7).
Based on these results, the relative contributions of CTLA-4 and
GITR in controlling suppression by Foxp3
+ Tregs during
persistent infection were investigated using antibody reagents that
block CTLA-4 or stimulate cells through GITR. We find that
CTLA-4 blockade alone is sufficient to recapitulate the effects of
Treg ablation on Salmonella infection tempo, while GITR
stimulation had no significant effect (Figure 8). These results are
consistent with the recent demonstration that CTLA-4 expression
on Foxp3
+ Tregs is essential for maintaining peripheral tolerance
[46,75]. Our results expand upon these findings by demonstrating
the importance of dynamic CTLA-4 expression on Tregs during
persistent infection that controls the kinetics of effector T cell
activation and overall infection tempo.
The increase in Treg suppressive potency at early time points
after Salmonella infection is consistent and may provide the
mechanistic basis that explains the relative immune suppression
previously observed during this infection [76,77,78,79,80]. Inter-
estingly, increased Treg suppressive potency early after infection
has also been described after viral and parasitic pathogens
[14,66,67]. Is enhanced Treg suppression early after infection
advantageous for the host, the pathogen, or both? Our ongoing
studies are aimed at identifying the signals activated during
Salmonella infection that trigger these changes, and Treg-intrinsic
molecules that sense and dictate this augmentation in suppressive
potency. Perhaps more intriguing are the molecular signals during
natural infection that trigger reductions in Treg suppression that
transform blunted immune effectors early after infection into more
potent mediators of pathogen clearance. Given the multiple
known pathogen-associated molecular patterns expressed by
Salmonella (e.g. LPS, flagellin, porins, and CpG DNA) that each
stimulate immune cells through defined Toll-like and other pattern
recognition receptors [81,82,83,84,85,86], together with the
enormous potential for cell intrinsic TLR-stimulation on Tregs
to alter their suppressive potency [34,35,36,38,87], it is tempting
to hypothesize that shifts in the expression of individual, multiple,
or cumulative TLR ligands during persistent infection controls the
relative expression of Treg-associated molecules that mediate
suppression. In this regard, our ongoing studies are also aimed at
identifying the Salmonella-specific ligands and their corresponding
host receptors that dictate these reductions in Treg suppression
during the progression of this persistent infection. We believe these
represent important prerequisites for developing new therapeutic
intervention strategies aimed at accelerating the transition to
pathogen clearance and further unraveling the pathogenesis of
typhoid fever caused by Salmonella infection.
Materials and Methods
Ethics statement
These experiments were conducted under University of Minne-
sota IACUC approved protocols (0705A08702 and 1004A80134)
entitled ‘‘Regulatory T cells dictate immunity during persistent
Salmonella infection’’. The guidelines followed for use of vertebrate
animals were also created by the University of Minnesota IACUC.
Mice
129SvJ males and C57BL/6 females were purchased from the
National Cancer Institute. F1 mice were generated by intercrossing
129SvJ males with C57BL/6 females. F1 Foxp3
GFP/2 and F1
Foxp3
DTR/2 hemizygous males and F1 Foxp3
DTR/WT heterozy-
gous females were derived by intercrossing 129SvJ males with
Foxp3
GFP/GFP or Foxp3
DTR/DTR females, respectively [23,24].
Both Foxp3
GFP/GFP and Foxp3
DTR/DTR females have been
backcrossed to C57BL/6 mice for over 15 generations. OT-1
TCR transgenic mice that contain T cells specific for the
OVA257–264 peptide were maintained on a RAG-deficient
CD90.1
+ background. All mice were used between 6–8 weeks
of age and maintained within specific pathogen-free facilities.
Bacteria
The virulent Salmonella enterica serotype Typhimurium
strain SL1344 has been described [29,88]. For infections,
SL1344 was grown to log phase in brain heart infusion media
at 37uC, washed and diluted with saline to a final concentration
of 1610
4 CFUs (for infection in F1 mice) or 1610
2 CFUs (for
infection in C57BL/6 mice) per 200 mL, and injected intrave-
nously through the lateral tail vein. At the indicated time points
after infection, mice were euthanized and the number of
recoverable Salmonella CFUs enumerated by plating serial
dilutions of the spleen and liver organ homogenate onto agar
plates.
Reagents
Antibodies and other reagents for cell surface, intracellular, or
intranuclear staining were purchased from BD Biosciences (San
Jose, CA) or eBioscience (San Diego, CA), and used according to
the manufacturers’ recommendations. For measuring cytokine
production by T cells, splenocytes were stimulated ex vivo with anti-
mouse CD3 and anti-mouse CD28 (each at 5 mg/mL) in the
presence of brefeldin A for 5 hours prior to intracellular cytokine
staining. Antibodies used for depletion, blocking or stimulation
experiments were purchased from BioXcell (West Lebanon, NH).
For T cell depletions, purified anti-mouse CD4 (clone GK1.5) and
anti-mouse CD8 (clone 2.43) antibodies were diluted to a final
concentration of 750 mg per 1 mL in sterile saline and injected
intraperitoneally on days 31 and 34 post-infection. Additional
injections were given on days 38 and 41 post-infection in
experiments where depletion was maintained up to 14 days. For
CTLA-4 blockade and GITR stimulation, anti-mouse CTLA4
(clone UC10-4F10), anti-mouse GITR (clone DTA-1), or isotype
control antibodies (hamster IgG or rat IgG, respectively) were
diluted to a final concentration of 500 mg per 1 mL in sterile saline
and injected intraperitoneally beginning either day 5 or day 37
post-infection followed by an additional injection of 250 mg of the
same antibody three days later [54,62,63,64]. For Foxp3
+ Treg
ablation, purified diphtheria toxin (DT; Sigma-Aldrich, St. Louis,
MO) was dissolved in saline and administered intraperitoneally to
F1 Foxp3
WT control, F1 Foxp3
DTR/2,o rF 1Foxp3
DTR/WT mice at
50 mg/kg body weight for two consecutive days beginning at
indicated time point after infection, and then maintained on a
reduced dose of DT thereafter (10 mg/kg body weight every other
day).
In vitro and in vivo suppression assays
For enumerating relative Treg suppression in vitro, Foxp3
+GFP
+
Tregs were isolated from F1 Foxp3
GFP/2 mice by enriching CD4
+
splenocytes first with negative selection using magnetic bead cell
isolation kits (Miltenyi Biotec, Auburn, CA). GFP
+(Foxp3
+) Tregs
were further purified by staining and sorting for CD4
+GFP
+ cells
using a FACSAria cell sorter. The purity of CD4
+Foxp3
+ cells
post-sort was verified to be .99%. Responder CD4
+ T cells were
isolated from naı ¨ve CD45.1
+ mice, CFSE-labeled under standard
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bottom plates (2610
4 cells/100 mL) at the indicated ratio of
purified GFP
+(Foxp3
+) Tregs and responder CD45.1
+CD4
+ T
cells. The relative suppressive potency for Tregs was enumerated
by comparing the proliferation (CFSE dilution) in responder cells
after co-culture and stimulation with anti-mouse CD3 and anti-
mouse CD28 antibodies (1 mg/mL each) for 4 days. For
enumerating relative Treg suppression in vivo,2 610
4 T cells from
OT-1 TCR transgenic mice on a RAG CD90.1
+ background were
diluted in 200 mL sterile saline and injected intravenously at the
indicated time points relative to Treg ablation or Salmonella
infection followed by intravenous injection of purified OVA257–264
peptide (400 mg) the following day. For each experiment,
the degree of OT-1 T cell expansion was enumerated five days
later.
MHC tetramer staining and enrichment
MHC class II tetramer staining and enrichment were per-
formed as described [61,69]. Briefly, splenocytes were harvested at
the indicated time points after infection and incubated with 5–
25 nM PE or APC-conjugated FliC431–439-specific tetramer in Fc
block for 1 hour at room temperature. These cells were then
incubated with anti-PE or anti-APC magnetic beads (Miltenyi
Biotec, Auburn, CA) for 30 minutes on ice and column purified
according to the manufacturer’s instructions. The bound and
unbound fractions were stained with fluorochrome-labeled
antibodies for cell surface and intracellular staining. The absence
of I-A
b FliC431–439 tetramer staining on CD8
+ T cells, and among
CD4
+ T cells in the unbound fraction of cells after bead
enrichment were used as independent markers to verify the
specificity of tetramer staining using methods described (data not
shown) [61].
Statistics
The differences in number of recoverable bacterial CFUs, and
the number and percent T cells among from different groups of
mice were evaluated using the Student’s t test (GraphPad, Prism
Software) with p,0.05 taken as statistical significance.
Supporting Information
Figure S1 Expression of Treg-associated molecules during
persistent Salmonella infection. The relative expression of defined
Treg cell-intrinsic molecules known to either enhance (CD39,
Granzyme B, ICOS, IL-10, PD-1, Tgf-b) or impede (OX40)
suppression on Foxp3
+ Tregs (line histogram) or Foxp3-negative
CD4
+ T cells (shaded histogram) at the indicated time points
during persistent infection. These data reflect six mice per time
point representative of two independent experiments each with
similar results. Bar, standard error.
Found at: doi:10.1371/journal.ppat.1001043.s001 (0.18 MB
DOC)
Figure S2 Relative impact of Treg ablation on recoverable
Salmonella CFUs in F1 control, Foxp3
DTR/2 and Foxp3
DTR/WT
mice. Number of recoverable Salmonella CFUs from the spleen
(top) and liver (bottom) in Treg-ablated F1 Foxp3
DTR/2 and
partially Treg-ablated F1 Foxp3
DTR/WT mice compared with
Treg-sufficient F1 control mice six days after the initiation of DT
treatment beginning day 5 post-infection. These data reflect eight
to twelve mice per group combined from three independent
experiments each with similar results. Bar, standard error.
*, p,0.05.
Found at: doi:10.1371/journal.ppat.1001043.s002 (0.08 MB
DOC)
Figure S3 Foxp3
+ Treg ablation eliminates the effects of CTLA-
4 blockade early after Salmonella infection. Number of recoverable
Salmonella CFUs (left) from spleen and liver following CTLA-4
blocking (a-CTLA-4) or isotype control (hamster IgG) antibody,
and DT treatment in F1 Foxp3
DTR mice each beginning day 5




+ T cells (right) for
each group of Salmonella infected mice. Bar, standard error.
Found at: doi:10.1371/journal.ppat.1001043.s003 (0.13 MB
DOC)
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